Position in HLN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,194,061
+$271,898 QoQ
Shares Held
219,187
+15.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Jun 30, 2025CallValue
$10,370
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $12,585,036 across 16 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
185,024 | $4,427,624 | |
| 2 | HLN |
Haleon plc
This page
|
219,187 | $2,194,061 | |
| 3 | ZTS |
Zoetis Inc.
|
15,150 | $1,790,881 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
42,625 | $884,895 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,888 | $659,266 | |
| 6 | VTRS |
Viatris Inc
|
41,557 | $561,435 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
890 | $527,752 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
26,488 | $490,557 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,194,061 | 219,187 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,922,163 | 190,125 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,238,909 | 138,117 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,085,780 | 104,704 | Shares | Sole | 2025-08-11 | |
| 2025-06-30 | $10,370 | 1,000 | Call | Sole | 2025-08-11 | |
| 2025-03-31 | $476,715 | 46,328 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $493,446 | 51,724 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $510,315 | 48,234 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $409,919 | 49,627 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $578,763 | 68,170 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $527,946 | 64,149 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $524,706 | 62,990 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $485,084 | 57,886 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $487,618 | 59,904 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $451,632 | 56,454 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $394,991 | 64,859 | Shares | Sole | 2022-10-14 | |
| No filing history on record for this holder in this stock. | ||||||